Approvals/CIMA-AEMPS/DALBAVANCINA BAXTER 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

DALBAVANCINA BAXTER 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Baxter Holding B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: b147f49c7f7d6730
Drug Cima Aemps Name: DALBAVANCINA BAXTER 500 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number: 90291
Holder Company Name: Baxter Holding B.V.
Marketing Company Name: Baxter S.L.
Holder Company Detail Path: /organization/baxter-holding-bv
Authorization Date: 2025-05-06
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 500 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Baxter Holding B.V.
Company Detail Path: /organization/baxter-holding-bv

DALBAVANCINA

500 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 6, 2025

Approval ID

b147f49c7f7d6730

Type

Standard